224 related articles for article (PubMed ID: 26935610)
1. Which questionnaires should we use to evaluate quality of life in patients with chronic graft-vs-host disease?
Perić Z; Desnica L; Duraković N; Ostojić A; Pulanić D; Serventi-Seiwerth R; Prenc E; Basak G; Vrhovac R; Pavletic SZ; Nemet D
Croat Med J; 2016 Feb; 57(1):6-15. PubMed ID: 26935610
[TBL] [Abstract][Full Text] [Related]
2. Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study.
Bonifazi F; Solano C; Wolschke C; Sessa M; Patriarca F; Zallio F; Nagler A; Selleri C; Risitano AM; Messina G; Bethge W; Herrera P; Sureda A; Carella AM; Cimminiello M; Guidi S; Finke J; Sorasio R; Ferra C; Sierra J; Russo D; Benedetti E; Milone G; Benedetti F; Heinzelmann M; Pastore D; Jurado M; Terruzzi E; Narni F; Völp A; Ayuk F; Ruutu T; Kröger N
Lancet Haematol; 2019 Feb; 6(2):e89-e99. PubMed ID: 30709437
[TBL] [Abstract][Full Text] [Related]
3. Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease.
Kurosawa S; Oshima K; Yamaguchi T; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Kohno A; Miyamura K; Umemoto Y; Teshima T; Taniguchi S; Yamashita T; Inamoto Y; Kanda Y; Okamoto S; Atsuta Y
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1749-1758. PubMed ID: 28669922
[TBL] [Abstract][Full Text] [Related]
4. Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation.
Herzberg PY; Heussner P; Mumm FH; Horak M; Hilgendorf I; von Harsdorf S; Hemmati P; Rieger K; Greinix H; Freund M; Lee SJ; Holler E; Wolff D
Biol Blood Marrow Transplant; 2010 Dec; 16(12):1707-17. PubMed ID: 20541028
[TBL] [Abstract][Full Text] [Related]
5. Improvement of quality of life in patients with steroid-refractory chronic graft-versus-host disease treated with the mTOR inhibitor everolimus.
Lutz M; Kapp M; Einsele H; Grigoleit GU; Mielke S
Clin Transplant; 2014 Dec; 28(12):1410-5. PubMed ID: 25287756
[TBL] [Abstract][Full Text] [Related]
6. Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium.
Pidala J; Kurland B; Chai X; Majhail N; Weisdorf DJ; Pavletic S; Cutler C; Jacobsohn D; Palmer J; Arai S; Jagasia M; Lee SJ
Blood; 2011 Apr; 117(17):4651-7. PubMed ID: 21355084
[TBL] [Abstract][Full Text] [Related]
7. Late Complications and Quality of Life after Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation.
Clavert A; Peric Z; Brissot E; Malard F; Guillaume T; Delaunay J; Dubruille V; Le Gouill S; Mahe B; Gastinne T; Blin N; Harousseau JL; Moreau P; Milpied N; Mohty M; Chevallier P
Biol Blood Marrow Transplant; 2017 Jan; 23(1):140-146. PubMed ID: 27751934
[TBL] [Abstract][Full Text] [Related]
8. Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study.
Fraser CJ; Bhatia S; Ness K; Carter A; Francisco L; Arora M; Parker P; Forman S; Weisdorf D; Gurney JG; Baker KS
Blood; 2006 Oct; 108(8):2867-73. PubMed ID: 16788100
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation.
Worel N; Biener D; Kalhs P; Mitterbauer M; Keil F; Schulenburg A; Höcker P; Dieckmann K; Fischer G; Rosenmayr A; Linkesch W; Hinterberger W; Lechner K; Greinix HT
Bone Marrow Transplant; 2002 Nov; 30(9):619-26. PubMed ID: 12407437
[TBL] [Abstract][Full Text] [Related]
10. Personality influences quality-of-life assessments in adult patients after allogeneic hematopoietic SCT: results from a joint evaluation of the prospective German Multicenter Validation Trial and the Fred Hutchinson Cancer Research Center.
Herzberg PY; Lee SJ; Heussner P; Mumm FH; Hilgendorf I; von Harsdorf S; Hemmati P; Rieger K; Greinix HT; Freund M; Holler E; Wolff D
Bone Marrow Transplant; 2013 Jan; 48(1):129-34. PubMed ID: 22609882
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.
Grube M; Holler E; Weber D; Holler B; Herr W; Wolff D
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1781-1791. PubMed ID: 27343720
[TBL] [Abstract][Full Text] [Related]
12. Symptoms, Cytokines, and Quality of Life in Patients Diagnosed with Chronic Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation.
Lynch Kelly D; Lyon DE; Ameringer SA; Elswick RK
Oncol Nurs Forum; 2015 May; 42(3):265-75. PubMed ID: 25901378
[TBL] [Abstract][Full Text] [Related]
13. Patient self-appraisal of change and minimal clinically important difference on the European organization for the research and treatment of cancer quality of life questionnaire core 30 before and during cancer therapy.
Hong F; Bosco JL; Bush N; Berry DL
BMC Cancer; 2013 Mar; 13():165. PubMed ID: 23537330
[TBL] [Abstract][Full Text] [Related]
14. The quality of life following allogeneic hematopoietic stem cell transplantation - a multicenter retrospective study.
Valkova V; Jircikova J; Trnkova M; Steinerova K; Keslova P; Lanska M; Koristek Z; Raida L; Krejci M; Kruntoradova K; Dolezal T; Benesova K; Cetkovsky P; Trneny M
Neoplasma; 2016; 63(5):743-51. PubMed ID: 27468878
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in pediatric patients after allogeneic SCT: development of the PedsQL Stem Cell Transplant module and results of a pilot study.
Lawitschka A; Güclü ED; Varni JW; Putz M; Wolff D; Pavletic S; Greinix H; Peters C; Felder-Puig R
Bone Marrow Transplant; 2014 Aug; 49(8):1093-7. PubMed ID: 24820217
[TBL] [Abstract][Full Text] [Related]
16. Spiritual well-being in long-term survivors with chronic graft-versus-host disease after hematopoietic stem cell transplantation.
Harris BA; Berger AM; Mitchell SA; Steinberg SM; Baker KL; Handel DL; Bolle JL; Bush EG; Avila D; Pavletic SZ
J Support Oncol; 2010; 8(3):119-25. PubMed ID: 20552925
[TBL] [Abstract][Full Text] [Related]
17. Sarcopenia among patients after allogeneic hematopoietic stem cell transplantation and the impact of chronic graft-versus-host disease.
Ljubas Kelecic D; Lelas A; Karas I; Desnica L; Vukic T; Sabol I; Vranesic Bender D; Serventi Seiwerth R; Peric Z; Durakovic N; Vitali Cepo D; Vrhovac R; Nemet D; Pavletic S; Pulanic D; Krznaric Z
J Cancer Res Clin Oncol; 2020 Nov; 146(11):2967-2978. PubMed ID: 32507973
[TBL] [Abstract][Full Text] [Related]
18. Impact of ocular graft-versus-host disease on visual quality of life in patients after allogeneic stem cell transplantation: questionnaire study.
Riemens A; Te Boome LC; Kalinina Ayuso V; Kuiper JJ; Imhof SM; Lokhorst HM; Aniki R
Acta Ophthalmol; 2014 Feb; 92(1):82-7. PubMed ID: 23601505
[TBL] [Abstract][Full Text] [Related]
19. Assessing the relationship between oral chronic graft-versus-host disease and global measures of quality of life.
DePalo J; Chai X; Lee SJ; Cutler CS; Treister N
Oral Oncol; 2015 Oct; 51(10):944-9. PubMed ID: 26277616
[TBL] [Abstract][Full Text] [Related]
20. Content Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive Interviews.
Merkel EC; Mitchell SA; Lee SJ
Biol Blood Marrow Transplant; 2016 Apr; 22(4):752-758. PubMed ID: 26751003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
